For: | Cidon EU. New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future. World J Gastrointest Oncol 2017; 9(1): 4-20 [PMID: 28144395 DOI: 10.4251/wjgo.v9.i1.4] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i1/4.htm |
Number | Citing Articles |
1 |
Parthik Patel, Karina Galoian. Molecular challenges of neuroendocrine tumors (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7680
|
2 |
Leonidas N. Diamantopoulos, Markos Kalligeros, Thorvardur R. Halfdanarson, Nikolaos Diamantis, Christos Toumpanakis. Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies. Biology 2023; 12(8): 1069 doi: 10.3390/biology12081069
|
3 |
Erica B. Sneider, Justin A. Maykel. Comprehensive Rectal Cancer Care. 2019; : 575 doi: 10.1007/978-3-319-98902-0_30
|
4 |
Aurelio Negro, Giovanni M. Rossi, Davide Nicoli, Annibale Versari, Enrico Farnetti, Rosaria Santi, Stefano De Pietri. Peptide Receptor Radionuclide Therapy–Induced Gitelman-like Syndrome. American Journal of Kidney Diseases 2017; 70(5): 725 doi: 10.1053/j.ajkd.2017.05.024
|
5 |
Steven D. Colquhoun. Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options. Liver Research 2018; 2(2): 92 doi: 10.1016/j.livres.2018.08.002
|
6 |
Marialuisa Appetecchia, Rosa Lauretta, Francesca Rota, Massimo Carlini. Abdominal Neuroendocrine Tumors. Updates in Surgery 2018; : 53 doi: 10.1007/978-88-470-3955-1_4
|
7 |
Faidon-Marios Laskaratos, Martyn Caplin. Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours. European Journal of Surgical Oncology 2019; 45(1): 52 doi: 10.1016/j.ejso.2018.03.012
|
8 |
Marta Benavent, Javier Sastre, Ignacio García Escobar, Angel Segura, Jaume Capdevila, Alberto Carmona, Isabel Sevilla, Teresa Alonso, Guillermo Crespo, Lourdes García, Neus Canal, Guillermo de la Cruz, Javier Gallego. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS). Health and Quality of Life Outcomes 2021; 19(1) doi: 10.1186/s12955-021-01688-x
|
9 |
Georgios S. Limouris. Liver Intra-arterial PRRT with 111In-Octreotide. 2021; : 75 doi: 10.1007/978-3-030-70773-6_6
|
10 |
Tiina Vesterinen, Helena Leijon, Harri Mustonen, Satu Remes, Aija Knuuttila, Kaisa Salmenkivi, Paula Vainio, Johanna Arola, Caj Haglund. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors. The Journal of Clinical Endocrinology & Metabolism 2019; 104(6): 2083 doi: 10.1210/jc.2018-01931
|
11 |
Feng Yin, Zi-Hao Wu, Jin-Ping Lai. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastroenterology 2022; 28(17): 1751-1767 doi: 10.3748/wjg.v28.i17.1751
|